Obesity-related glomerulopathy is associated with elevated WT1 expression in podocytes
- 19 March 2024
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 48 (8) , 1080-1091
Abstract
Background The prevalence of obesity is increasing worldwide at an alarming rate. In addition to the increased incidence of cardiovascular and metabolic diseases, obesity is the most potent risk factor for developing chronic kidney disease (CKD). Although systemic events such as hemodynamic factors, metabolic effects, and lipotoxicity were implicated in the pathophysiology of obesity-related glomerulopathy (ORG) and kidney dysfunction, the precise mechanisms underlying the association between obesity and CKD remain unexplored. Methods In this study, we employed spontaneous WNIN/Ob rats to investigate the molecular events that promote ORG. Further, we fed a high-fat diet to mice and analyzed the incidence of ORG. Kidney functional parameters, micro-anatomical manifestations, and podocyte morphology were investigated in both experimental animal models. Gene expression analysis in the rodents was compared with human subjects by data mining using Nephroseq and Kidney Precision Medicine Project database. Results WNIN/Ob rats were presented with proteinuria and several glomerular deformities, such as adaptive glomerulosclerosis, decreased expression of podocyte-specific markers, and effacement of podocyte foot process. Similarly, high-fat-fed mice also showed glomerular injury and proteinuria. Both experimental animal models showed increased expression of podocyte-specific transcription factor WT1. The altered expression of putative targets of WT1 such as E-cadherin, podocin (reduced), and α-SMA (increased) suggests elevated expression of WT1 in podocytes elicits mesenchymal phenotype. Curated data from CKD patients revealed increased expression of WT1 in the podocytes and its precursors, parietal epithelial cells. Conclusion WT1 is crucial during nephron development and has minimal expression in adult podocytes. Our study discovered elevated expression of WT1 in podocytes in obesity settings. Our analysis suggests a novel function for WT1 in the pathogenesis of ORG; however, the precise mechanism of WT1 induction and its involvement in podocyte pathobiology needs further investigation.Keywords
This publication has 65 references indexed in Scilit:
- Role of Podocyte Injury in Glomerulosclerosis2019
- Hypoxia induces ZEB2 in podocytes: Implications in the pathogenesis of proteinuriaJournal of Cellular Physiology, 2018
- The Renal Pathology of ObesityKidney International Reports, 2017
- Glomerulopathy Associated With Moderate ObesityKidney International Reports, 2016
- Altered ubiquitin-proteasome system leads to neuronal cell death in a spontaneous obese rat modelBiochimica et Biophysica Acta (BBA) - General Subjects, 2014
- A Wt1-Controlled Chromatin Switching Mechanism Underpins Tissue-Specific Wnt4 Activation and RepressionDevelopmental Cell, 2011
- Young Scholars Award Lecture: Intratubular Angiotensinogen in Hypertension and Kidney DiseasesAmerican Journal of Hypertension, 2006
- The wt1‐heterozygous mouse; a model to study the development of glomerular sclerosisThe Journal of Pathology, 2003
- WT-1 is required for early kidney developmentCell, 1993
- Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndromeCell, 1991